Zhejiang Hisun Pharmaceutical Co.,Ltd. (600267.SH): S-Adenosyl-L-methionine 1,4-butanedisulfonate Receives US Self-GRAS Certification

Stock News10-09

Zhejiang Hisun Pharmaceutical Co.,Ltd. (600267.SH) announced that its product S-adenosyl-L-methionine 1,4-butanedisulfonate has recently completed the Self-GRAS (Self-affirmed Generally Recognized as Safe) scientific evaluation in accordance with US FDA GRAS guidelines and received unanimous approval from the expert panel, officially obtaining US Self-GRAS certification.

The company's S-adenosyl-L-methionine 1,4-butanedisulfonate receiving Self-GRAS certification means that this product has undergone scientific evaluation procedures and officially obtained market access qualification for the US market. It can now be sold and used as a safe dietary ingredient in the US market as well as other international markets that recognize US GRAS certification. This further enriches the company's profit structure and establishes a key foundation for the global expansion of the company's dietary supplement business.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment